Pilot-Study to Explore Metabolic Signature of Type 2 Diabetes: A Pipeline of Tree-Based Machine Learning and Bioinformatics Techniques for Biomarkers Discovery
Open Access
Abstract
Background: This study aims to identify unique metabolomics biomarkers associated with Type 2 Diabetes (T2D) and develop an accurate diagnostics model using tree-based machine learning (ML) algorithms integrated with bioinformatics techniques. Methods: Univariate and multivariate analyses such as fold change, a receiver operating characteristic curve (ROC), and Partial Least-Squares Discriminant Analysis (PLS-DA) were used to identify biomarker metabolites that showed significant concentration in T2D patients. Three tree-based algorithms [eXtreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine (LightGBM), and Adaptive Boosting (AdaBoost)] that demonstrated robustness in high-dimensional data analysis were used to create a diagnostic model for T2D. Results: As a result of the biomarker discovery process validated with three different approaches, Pyruvate, D-Rhamnose, AMP, pipecolate, Tetradecenoic acid, Tetradecanoic acid, Dodecanediothioic acid, Prostaglandin E3/D3 (isobars), ADP and Hexadecenoic acid were determined as potential biomarkers for T2D. Our results showed that the XGBoost model [accuracy = 0.831, F1-score = 0.845, sensitivity = 0.882, specificity = 0.774, positive predictive value (PPV) = 0.811, negative-PV (NPV) = 0.857 and Area under the ROC curve (AUC) = 0.887] had the slight highest performance measures. Conclusions: ML integrated with bioinformatics techniques offers accurate and positive T2D candidate biomarker discovery. The XGBoost model can successfully distinguish T2D based on metabolites.Keywords
Funding Information
- Deanship of Scientific Research, King Khalid University, Kingdom of Saudi Arabia (RGP - 2/286/44)
This publication has 36 references indexed in Scilit:
- Investigation of metabolic pathways from gut microbiome analyses regarding type 2 diabetes mellitus using artificial neural networksDiscover Artificial Intelligence, 2023
- Prediction of type 2 diabetes using genome-wide polygenic risk score and metabolic profiles: A machine learning analysis of population-based 10-year prospective cohort studyEBioMedicine, 2022
- An Update on the Epidemiology of Type 2 DiabetesEndocrinology and Metabolism Clinics of North America, 2021
- FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activityCell Reports, 2021
- Environmental and genetic contributions to diabetesMetabolism, 2019
- Salivary diagnostics on paper microfluidic devices and their use as wearable sensors for glucose monitoringAnalytical and Bioanalytical Chemistry, 2019
- Early metabolic markers identify potential targets for the prevention of type 2 diabetesDiabetologia, 2017
- Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytesKidney Research and Clinical Practice, 2014
- Multivariate classification analysis of metabolomic data for candidate biomarker discovery in type 2 diabetes mellitusMetabolomics, 2008
- Multi‐class cancer subtype classification based on gene expression signatures with reliability analysisFEBS Letters, 2004